Answers are grounded in this paper and cite their sources.
Evaluates immune recognition mechanism in viral strains, suggesting new vaccine design principles.
Based on the SFL theoretical framework & G₀ fixed architecture principle derived from previous serial papers, this paper reinterprets the immune recognition mechanism between the human immune system and variable viral strains, providing a new theoretical basis for universal vaccine design and immunological evaluation. Traditional immunological perspectives generally attribute repeated vaccine inefficiency and viral phenotypic drift to adaptive immune escape evolution, which requires further rational supplementation and revision under the unified complex system framework. Combined with the core conclusions of bounded genetic damage and fixed viral architecture established in SFL-VIR-01, SFL-VIR-02 and SFL-VIR-03, this study clarifies that all viral phenotypic changes originate from cumulative genetic damage ΔG_d, while the core species-defining genetic structure G₀ remains stably invariant throughout repeated replication and transmission. The human immune system tends to identify and target the stable core framework of pathogens rather than dynamically changing damaged phenotypic fragments. The decline in vaccine protective effect mainly results from phenotypic deviation caused by continuous damage accumulation, instead of evolutionary reconstruction of viral core identity. Combined with the unified system state equation: G=G₀+ΔG_d(+)-ΔG_d(-) Consistent with the universal dissipation stability constraint of complex systems: ε(T)=o(1 / T) This paper verifies that viral mutants cannot alter their fundamental species attributes defined by G₀ architecture. Long-term immune protection can be achieved by vaccine strategies targeting invariant core structures, which avoids the limitations brought by continuous iteration of mutant-specific vaccines. This immune recognition mechanism maintains isomorphic consistency with the stable feature identification logic applied in biological systems, electronic hardware and artificial intelligence monitoring systems in the SFL-EAI series, further expanding the cross-domain applicability of the SFL unified theoretical system.
No takes yet. Share an insight, caveat, or question.
FOO SENG ANG (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: